Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).

    Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D, Hilgenberg S, Smart R, Brown RH, Cudkowicz ME.

    Amyotroph Lateral Scler. 2006 Sep;7(3):173-82.PMID: 16963407 [PubMed - indexed for MEDLINE]Related articles

    2.

    Transformation: from medical student to patient.

    Hilgenberg S.

    Ann Intern Med. 2006 May 16;144(10):779-80. No abstract available. PMID: 16702597 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease.

    Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Beal MF.

    Neurochem Int. 2003 Aug;43(3):191-6.PMID: 12689599 [PubMed - indexed for MEDLINE]Related articles

    4.

    Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.

    Lorenzl S, Albers DS, LeWitt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME, Beal MF.

    J Neurol Sci. 2003 Mar 15;207(1-2):71-6.PMID: 12614934 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...